最新新闻

Sean Hart Named Chief Business Officer of 乔治临床( George Clinical )

SYDNEY, October 8, 2019 – 乔治临床( George Clinical ), a global scientifically-driven clinical research organization (CRO), today announced the promotion of Sean Hart to the new role of Chief Busi […]

了解更多

2019年10月8日

乔治临床( George Clinical ) Grows European Presence with New Location in the United Kingdom

LONDON, August 19, 2019 – 乔治临床( George Clinical ), a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and mor […]

了解更多

2019年9月17日

The George Institute and UNSW Founders Build Ecosystem for Health Innovations

In what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, University of New South Wales—Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program dubbed Health10x designed to accelerate and scale up health focused start-ups. The Health10x program was conceived […]

了解更多

2019年9月11日

Professor Bruce Neal Appointed Executive Director of The George Institute

乔治临床( George Clinical ) is pleased to announce that Dr. Bruce Neal has been appointed Executive Director of The George Institute Australia effective September 1.   Neal was a founding member o […]

了解更多

2019年9月5日

WHO Endorsement of Simpler Drug Treatment for Blood Pressure Will Improve Treatment Availability for 1 Billion People

乔治临床( George Clinical ) welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization (WHO) Essential Medicines List (EML) in r […]

了解更多

2019年7月31日

The George Institute Researchers Find Diabetes Increases the Risk of Heart Failure for Women at a Higher Rate

A global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men.  Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]

了解更多

2019年7月19日

Big and Small Pharma Enjoy a Significant Opportunity to Leverage India for Trials

The Indian subcontinent deserves to be considered by pharmaceutical or biotech firms examining clinical trial locations, and veteran industry players may be surprised to learn India is already […]

了解更多

2019年7月17日

Award Highlights 乔治临床( George Clinical ) as Leading Employer in Asia-Pacific Region

Last year 乔治临床( George Clinical ) gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong.  The Mandatory Provident Fund Sche […]

了解更多

2019年7月13日

乔治临床( George Clinical ) Announces the Appointment of Meelian Hoh as Chief Financial Officer

SYDNEY, June 17, 2019 – 乔治临床( George Clinical ), a global scientifically driven CRO, today announced the appointment of Meelian Hoh to the role of Chief Financial Officer. With extensive finan […]

了解更多

2019年6月18日

乔治临床( George Clinical ) Welcomes FDA Framework for Real World Evidence Program

December of 2018 saw the FDA release their “Framework For Evaluating the Potential Use of Real-World Evidence (RWE)” to support the approval of a new indication for a drug already approved und […]

了解更多

2019年6月1日

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )